Publications by authors named "Elena Di Daniel"

13Publications

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors.

Immunology 2021 Jan 30;162(1):84-91. Epub 2020 Oct 30.

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

View Article and Find Full Text PDF
January 2021

Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.

Br J Pharmacol 2019 09 11;176(18):3515-3532. Epub 2019 May 11.

Alzheimer's Research UK Oxford Drug Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

View Article and Find Full Text PDF
September 2019

A novel high-content imaging-based technique for measuring binding of Dickkopf-1 to low-density lipoprotein receptor-related protein 6.

J Pharmacol Toxicol Methods 2019 Jan - Feb;95:47-55. Epub 2018 Nov 23.

Alzheimer's Research UK Oxford Drug Discovery Institute, University of Oxford, NDM Research Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7FZ, UK. Electronic address:

View Article and Find Full Text PDF
March 2019

Oscillating Magnet Array-Based Nanomagnetic Gene Transfection: A Valuable Tool for Molecular Neurobiology Studies.

Nanomaterials (Basel) 2017 Jan 29;7(2). Epub 2017 Jan 29.

J. Crayton Pruitt Family Department of Biomedical Engineering, Department of Material Science and Engineering, and Institute for Cell Engineering and Regenerative Medicine-ICERM, University of Florida, P.O. Box 116131, Gainesville, Florida, FL 32611, USA.

View Article and Find Full Text PDF
January 2017

Abnormalities in α/β-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice.

Int J Neuropsychopharmacol 2011 Aug 14;14(7):941-53. Epub 2010 Oct 14.

Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases, University of Milano, Italy.

View Article and Find Full Text PDF
August 2011

Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.

Biochem Soc Trans 2009 Oct;37(Pt 5):1139-43

Synaptic Plasticity and Neural Network Dynamics DPU, Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex, UK.

View Article and Find Full Text PDF
October 2009

Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine.

Biochem Soc Trans 2009 Oct;37(Pt 5):1080-4

Neurosciences Centre of Excellence for Drug Discovery, Medicines Research Centre, GlaxoSmithKline S.p.A., Via Fleming 4, 37135, Verona, Italy.

View Article and Find Full Text PDF
October 2009

The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.

Mol Cell Neurosci 2006 May-Jun;32(1-2):27-36. Epub 2006 Mar 13.

Schizophrenia and Bipolar Neurophysiology and Pharmacology Research Department, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, Third Avenue, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
September 2006

Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.

Bipolar Disord 2005 Feb;7(1):33-41

Schizophrenia and Bipolar Disorder Research Department, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, Harlow, Essex, UK.

View Article and Find Full Text PDF
February 2005

Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells.

J Biol Chem 2002 Jun 19;277(26):23330-5. Epub 2002 Apr 19.

Systems Research-Kinase Biology Discovery Research, GlaxoSmithKline Pharmaceuticals, Harlow, Essex, CM19 5AD, United Kingdom.

View Article and Find Full Text PDF
June 2002